QTc interval and its variability in patients with schizophrenia and healthy subjects: Implications for a thorough QT study

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1535-1540

  Hingorani, Pooja ^a   Karnad, Dilip R ^a,b   Natekar, Mili ^a   Kothari, Snehal ^a   Narula, Dhiraj ^a   Lokhandwala, Yash ^a,c  

^a IQVIA   (United States)

^b Seven Hills Hospital   (India)

^c Arrhythmia Associates   (India)

Author keywords

Antipsychotic drugs; cardiac repolarization; electrocardiography; heart rate; within subject variability

Indexed keywords

ARIPIPRAZOLE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; RETROSPECTIVE STUDY; SAMPLE SIZE; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84867262916     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712000077     Document Type: Article

References (26)

1. Addis S, Stampfer HG, Lyons Z (2003). Circadian heart rate patterns and schizophrenia. Abstracts of the International Congress on Schizophrenia Research. Schizophrenia Research 60 (Suppl.), 3.
2. Alexander PE, Van Kammen DP, Bunney Jr. WE (1979). Serum calcium and magnesium levels in schizophrenia ii. possible relationship to extrapyramidal symptoms. Archives of General Psychiatry 36, 1372-1377.
3. Alvarez PA, Pahissa J (2010). QT alterations in psychopharmacology: proven candidates and suspects. Current Drug Safety 5, 97-104.
4. Bär KJ, Koschke M, Boettger MK, Berger S, et al. (2007). Acute psychosis leads to increased QT variability in patients suffering from schizophrenia. Schizophrenia Research 95, 115-123.
5. Bär KJ, Letzsch A, Jochum T, Wagner G, et al. (2005). Loss of efferent vagal activity in acute schizophrenia. Journal of Psychiatric Research 39, 519-527.
6. Berger RD, Kasper EK, Baughman KL, Marban E, et al. (1997). Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 96, 1557-1565.
7. Bexton RS, Vallin HO, Camm AJ (1986). Diurnal variation of the QT interval-influence of the autonomic nervous system. British Heart Journal 55, 253-258.
8. Cardiac Safety in Schizophrenia Group (CSISG) (2002). Minimizing the risks with significant QTc prolongation in people with schizophrenia : a consensus statement by Cardiac Safety in Schizophrenia Group. Australasian Psychiatry 10, 115-124.
9. Chapel S, Hutmacher MM, Haig G, Bockbrader H, et al. (2009). Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation. Journal of Clinical Pharmacology 49, 1297-1308.
10. Glassman AH, Bigger JT (2001). Antipsychotic drugs: prolonged QTc interval, Torsade de pointes, and sudden death. American Journal of Psychiatry 158, 1774-1782.
11. Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal 150, 1115-1121.
12. Jindal RD, Keshavan MS, Eklund K, Stevens A, et al. (2009). Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophrenia Research 113, 176-180.
13. Julious SA (2004). Sample sizes for clinical trials with normal data. Statistics in Medicine 2312, 1921-1986.
14. Lam MH, Chau SW, Wing YK (2009). High prevalence of hypokalemia in acute psychiatric inpatients. General Hospital Psychiatry 31, 262-265.
15. Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM (2002). Autonomic nervous system influences on QT interval in normal subjects. Journal of the American College of Cardiology 39, 1820-1826.
16. Morganroth J, Brazovich FV, McDonald JT, Jacobs RA (1991). Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. American Journal of Cardiology 67, 774-776.
17. Myredal A, Karlsson AK, Johansson M (2008). Elevated temporal lability of myocardial repolarization after coronary artery bypass grafting. Journal of Electrocardiology 41, 698-702.
18. Nielsen J, Graff C, Kanters JK, Toft E, et al. (2011). Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs 25, 473-490.
19. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, et al. (2000). QTcinterval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355, 1048-1052.
20. RettenbacherMA, Eder-Ischia U, Bader A, Edlinger M, et al. (2005). QTc variability in schizophrenia patients treated with antipsychotics and healthy controls. Journal of Clinical Psychopharmacology 25, 206-210.
21. Sala M, Vicentini A, Brambilla P, Montomoli C, et al. (2005). QT interval prolongation related to psychoactive drug treatment : a comparison of monotherapy vs. polytherapy. Annals of General Psychiatry 4, 1-6.
22. Salvi V, Karnad DR, Panicker GK, Kothari S (2010). Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development. British Journal of Pharmacology 159, 34-48.
23. Titier K, Girodet PO, Verdoux H, Molimard M, et al. (2005). Atypical antipsychotics : from potassium channels to torsade de pointes and sudden death. Drug Safety 28, 35-51.
24. Toichi M, Kubota Y, Murai T, Kamio Y, et al. (1999). The influence of psychotic states on the autonomic nervous system in schizophrenia. International Journal of Psychophysiology 31, 147-154.
25. Valkonen-Korhonen M, Tarvainen MP, Ranta-Aho P, Karjalainen PA, et al. (2003). Heart rate variability in acute psychosis. Psychophysiology 40, 716-726.
26. Vancampfort D, Probst M, Scheewe T, Maurissen K, et al. (2011). Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia. Schizophrenia Research 129, 122-127.